Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

TCDD reduces EGF receptors in the liver, affecting growth and development.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Erlotinib can cause excessive eyelash growth.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

EGFR inhibitors for lung cancer can cause severe skin issues.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Erlotinib can cause hair loss as a side effect.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

ZD1839 can cause skin issues like acne and hair changes.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Pig skin cells can turn into mesodermal cells but lose their ability to become neural cells.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Cactus extract from Notocactus ottonis may help promote hair growth.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.